Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 51 (3) , 401-408
- https://doi.org/10.1016/s0015-0282(16)60544-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Impact of gestrinone on the course of asymptomatic endometriosis.BMJ, 1987
- Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patientsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1986
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- The effectiveness of danazol on subsequent fertility in minimal endometriosisFertility and Sterility, 1982
- Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-upFertility and Sterility, 1982
- Classification of EndometriosisFertility and Sterility, 1979
- Clinical Studies with an Antigonadotropin-DanazolFertility and Sterility, 1971
- The use of newer progestins in the treatment of endometriosisAmerican Journal of Obstetrics and Gynecology, 1958
- THE USE OF STILBESTROL FOR ENDOMETRIOSISSouthern Medical Journal, 1948